On June 22, the signing ceremony of Chengdu High-tech Medical Association and Zhongguancun Group Beijing Lingchuang Precision Medicine Health Industry Investment Co., Ltd. was held in the conference room on the second floor of Chengdu High-tech Medical Association.

      The two parties will cooperate in academic conferences and exhibitions, co-construction of academic organizations, innovation platform construction, technological and financial empowerment, etc., and join hands with the "three medical" field to win the future of the biopharmaceutical industry. Zou Guochun, general manager of Beijing Lingchuang Medical·Chengdu Medical City International Science and Technology Innovation Community, Wang Meng, deputy general manager, Zeng Bin, secretary general of Chengdu High-tech Medical Association, Lin Fan, deputy secretary general, and Bu Wei, deputy director of the Medical-Industrial Integration Collaborative Innovation Center, attended the signing ceremony. ceremony. Zhang Yan, deputy general manager of Zhongguancun Group Beijing Lingchuang Precision Medicine and Health Industry Investment Co., Ltd., and Zhen Jun, general manager of the general health division of Zhongguancun Group Technology Leasing Co., Ltd. attended and communicated in the form of a video conference.

 The two sides signed a strategic cooperation framework agreement

    Deputy General Manager Zhang Yan said that this signing has far-reaching significance and impact on both parties. He hopes to have deeper cooperation in the transformation of medical achievements, coordinated development of the park and health management services in the future, and further gather resources from various parties to boost biomedicine. The industrial ecological chain will be better and stronger.

     Secretary-General Zeng Bin pointed out that the two sides should achieve strong alliances, in-depth cooperation and inclusive development based on their own characteristics and advantages. The first is to focus on cooperation projects, mutual promotion and win-win results, and to promote the implementation of projects such as the Co-creation International Science and Technology Innovation Center and the Three-Medical Science and Technology Innovation Financial Service Center; the second is to expand the fields of cooperation, exchange and share, and promote more biopharmaceutical companies to land and improve The third is to deepen the cooperation mechanism, interact and make progress together, enrich and expand multi-level and diversified cooperation in the biopharmaceutical industry, capital, and market, and explore new methods and ideas for accelerating the development of the biopharmaceutical industry.

Editor in charge: Cao Lisha

Review: Lin Fan